Joshua Eizen Sells 5,945 Shares of Anthem (NASDAQ:ANTX) Stock

Anthem, Inc. (NASDAQ:ANTX) insider Joshua Eizen sold 5,945 shares of Anthem stock in a transaction that occurred on Wednesday, July 8th. The stock was sold at an average price of $4.17, for a total value of $24,790.65. Following the sale, the insider directly owned 206,554 shares in the company, valued at $861,330.18. The trade was a 2.80% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Anthem Price Performance

Shares of NASDAQ ANTX traded down $0.13 during trading hours on Friday, reaching $4.50. The stock had a trading volume of 591,722 shares, compared to its average volume of 422,831. The business’s fifty day moving average is $4.60 and its two-hundred day moving average is $3.11. The company has a market cap of $162.09 million, a price-to-earnings ratio of -4.09 and a beta of -0.99. Anthem, Inc. has a twelve month low of $1.00 and a twelve month high of $6.91.

Anthem (NASDAQ:ANTX) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.06).

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Finally, Leerink Partners raised Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target on the stock in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $9.00.

Institutional Trading of Anthem

Hedge funds have recently modified their holdings of the company. Spruce Street Capital LP bought a new position in shares of Anthem in the first quarter valued at approximately $5,576,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem during the 1st quarter worth approximately $54,000. Commodore Capital LP acquired a new stake in Anthem during the 1st quarter valued at $7,981,000. ADAR1 Capital Management LLC bought a new position in Anthem in the 1st quarter valued at $47,000. Finally, Ally Bridge Group NY LLC acquired a new position in Anthem in the first quarter worth $1,800,000. Institutional investors and hedge funds own 90.47% of the company’s stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.